Welcome Letter

Dear Industry Colleagues,

On behalf of Israel Advanced Technology Industries Association (IATI), and the Steering Committee, it is our great pleasure to invite you to MIXiii Health-Tech.IL 2026, Israel’s premier international Health-Tech and life science conference and exhibition. The event will take place on June 29-30, 2026, at the International Convention Center (ICC) in Jerusalem.

MIXiii Health-Tech.IL is led and organized by IATI, Israel’s umbrella organization of the high-tech, life sciences, and advanced technology industries. IATI works to strengthen and promote Israel’s thriving life science and technology sector by creating an environment that supports innovation, developing international business connections, promoting collaborations between industry and academia, and influencing government policy to advance the country’s life sciences industries.

The conference offers a unique platform where global leaders in healthcare, technology, and science come together to explore breakthroughs, forge collaborations, and showcase Israel’s dynamic health-tech ecosystem. Supported by key Israeli government offices and industry partners, the conference reflects the resilience, ingenuity, and collaborative spirit that drive innovation in Israel and beyond.

This year, the conference will place a special focus on connecting venture capital funds with Israeli startup companies, creating unique opportunities for investment, collaboration, and growth. The program features a diverse agenda, including multiple thematic tracks, expert lectures, and panel discussions. Topics include emergency medicine (which has gained particular importance during the recent conflict), tech-bio, healthcare venture building, homecare and remote monitoring, emerging technologies from Israeli academia, innovation in ophthalmology, and more.

MIXiii Health-Tech.IL is the only event organized by the industry, for the industry, ensuring every session is relevant and informative. Over two days, participants will have the opportunity to connect with researchers, entrepreneurs, investors, policymakers, and thought leaders, fostering partnerships that can shape the future of healthcare in Israel and beyond.

Alongside the scientific program, the event offers extensive networking opportunities, business-to-business meetings, and informal gatherings, providing the ideal setting for building relationships, sharing ideas, and exploring new ventures.

We warmly invite you to join us in Jerusalem for an inspiring and impactful event that celebrates

We look forward to welcoming you to MIXiii Health-Tech.IL 2026.

Karin Mayer Rubinstein
Karin Mayer RubinsteinCEO & President Israel Advanced Technology Industries Association (IATI)
Karin is the CEO and President of Israel Advanced Technology Industries Association (IATI), the umbrella organization of Israel’s Tech ecosystem. IATI is on a mission to foster business certainty and stability for advancing Israel’s tech Industries.
Yaacov Michlin
Yaacov MichlinConference Chair & CEO, BioLight Life Sciences Ltd.
CEO of Biolight [TASE:BOLT], The leading Israeli company in the area of development and investments in Ophthalmology and eye related drugs, devices and digital health projects. Chairman of MIXIII Health-Tech.IL and leading life sciences activity in IATI.

Main Topics

Among the Speakers

Dr. Eugene de Juan, MD, Jean Kelly Stock Distinguished Professor of Ophthalmology
Dror Bin, CEO, Israel Innovation Authority
Prof. Yifat Merbl, Department of Systems Immunology, Weizmann Institute of Science
Prof. Ran Balicer, Chief Innovation Officer & Deputy Director General, Clalit Health Services
Mark Sabag, Executive Vice President – Head of International Markets, Teva Pharmaceuticals
Vered Gigi, PhD, VP, Ambassador, Ex-US, Curie.Bio
Prof. Ronit Satchi-Fainaro, Head, Cancer Research and Nanomedicine Laboratory, Faculty of Medicine, Sagol School of Neuroscience, Tel Aviv University
Mati Gill, CEO, AION Labs
Prof. Anat Loewenstein, MD, MHA, VP Ambulatory Services and Head of Retina, Tel Aviv Medical Center, Tel Aviv, Israel
Sigal Azmon, Chief Executive Officer & Founder, Medix Global
Inbal Mayan, MD, Chief Medical Officer, Sabar Health
Gil Shai, Managing Partner, Meron Capital
Ron Sabar, MD, MBA, Founding President, Sabar Health
Dr. Daniel Trotzky, Deputy Medical Director and Director of Emergency Medicine Services & Preparedness, Tel Aviv Sourasky Medical Center (Ichilov)
Sam Cronin, PhD, Partner, A-Squared Ventures
Dr. Noam Solomon, Founder and CEO, Immunai

Ophthalmology in Israel  Steering Committee

Nahum Ferera
Nahum FereraCEO & Co-Founder, EyeYon Medical
Daphne Haim-Langford, PhD
Daphne Haim-Langford, PhDFounder & CEO, Tarsier Pharma
Prof. Anat Loewenstein, MD, MHA
Prof. Anat Loewenstein, MD, MHAVP Ambulatory Services and Head of Retina, Tel Aviv Medical Center, Tel Aviv
Daria Lemann-Blumenthal, LL.B., EMBA
Daria Lemann-Blumenthal, LL.B., EMBACEO, NanoDrops Ltd.